HER2-positive Circulating Tumor Cells
1 clinical trials · Condition
◉ Watch HER2-positive Circulating Tumor Cells
| Record | Firm | Date |
|---|---|---|
| DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs (NCT01619111) | Prof. Wolfgang Janni | 2012-02-01 |
Track HER2-positive Circulating Tumor Cells automatically
Every clearance here is in the API, with alerts when new ones post.